Connection

Alessandro Armuzzi to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Alessandro Armuzzi has written about Antibodies, Monoclonal, Humanized.
Alessandro Armuzzi
Connection Strength
0.207
Antibodies, Monoclonal, Humanized
  1. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases. Expert Rev Clin Immunol. 2018 09; 14(9):751-759.
    View in: PubMed
    Score: 0.159
  2. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study. Inflamm Bowel Dis. 2018 10 12; 24(11):2442-2451.
    View in: PubMed
    Score: 0.040
  3. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2017 04; 49(4):338-358.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.